Gelir vergisi gideri · 2025 mali yılı
| 1 | Johnson & JohnsonJNJ | $5,8B |
|---|---|---|
| 2 | Eli LillyLLY | $5,1B |
| 3 | Novo Nordisk A SNVO | $4,3B |
| 4 | MerckMRK | $2,8B |
| 5 | AbbVieABBV | $2,4B |
| 6 | Bristol Myers SquibbBMY | $2,3B |
| 7 | AstraZenecaAZN | $2,2B |
| 8 | HCA HealthcareHCA | $2,1B |
| 9 | Abbott LaboratoriesABT | $1,9B |
| 10 | UnitedHealth GroupUNH | $1,9B |